Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

ML355

Copy Product Info
🥰Excellent
Catalog No. T4347Cas No. 1532593-30-8

ML355, a specific, effective 12-Lipoxygenase(12-LOX) inhibitors(IC50=0.34 μM), possess favorable ADME properties.

ML355

ML355

Copy Product Info
🥰Excellent
Purity: 98.02%
Catalog No. T4347Cas No. 1532593-30-8
ML355, a specific, effective 12-Lipoxygenase(12-LOX) inhibitors(IC50=0.34 μM), possess favorable ADME properties.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$38In StockIn Stock
5 mg$98In StockIn Stock
10 mg$163In StockIn Stock
25 mg$313In StockIn Stock
50 mg$513In StockIn Stock
100 mg$787In StockIn Stock
200 mg$1,070In StockIn Stock
1 mL x 10 mM (in DMSO)$103In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.02%
Appearance:Solid
Color:White to Yellow
Contact us for more batch information

Resource Download

Product Introduction

ML355 AI Summary
ML355 demonstrates a wide range of bioactivities. It has moderate oral bioavailability in CD-1 mice (F=19.8% at 30 mg/kg) and a relatively short half-life at 3 mg/kg via both oral and intravenous routes. It inhibits 12-LOX in mouse cells and human platelets with IC50 values of 1000.0 nM and 340.0 nM, respectively, and shows uncompetitive inhibition of N-terminal His6-tagged human platelet 12-LOX (Ki=350.0 nM) as well as competitive inhibition of this enzyme (Ki=720.0 nM). The compound is stable in PBS buffer, mouse plasma, and liver microsomes, and exhibits good solubility in PBS buffer at pH 7.4. It has weaker inhibitory activity against human 5-LOX and 15-LOX2 but selectively inhibits human reticulocyte 15-LOX1 over human platelet 12-LOX with an IC50 ratio of 29.0. In addition to its enzymatic inhibition properties, ML355 shows antiviral activity. It exhibits 6.99% inhibition of the SARS-CoV-2 3CL-Pro protease at 20 μM and inhibits SARS-CoV-2 induced cytotoxicity in VERO-6 cells at 10 μM following 48 hours of exposure to the virus. The compound affects various cell lines, impacting growth rates in HEK293T, U2OS, and human fibroblast cells with growth rates ranging from 0.18 to 1.0, indicating diverse effects on cell viability. In terms of protein stability, ML355 generally increases the thermal stability (melting temperature, TM) of different protein domains, although it decreases TM in one specific domain, signifying both stabilizing and destabilizing effects dependently on the targeted protein region..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
ML355, a specific, effective 12-Lipoxygenase(12-LOX) inhibitors(IC50=0.34 μM), possess favorable ADME properties.
Targets&IC50
12-LOX:0.34 μM
Chemical Properties
Molecular Weight441.52
FormulaC21H19N3O4S2
Cas No.1532593-30-8
SmilesCOc1cccc(CNc2ccc(cc2)S(=O)(=O)Nc2nc3ccccc3s2)c1O
Relative Density.1.481 g/cm3 (Predicted)
Storage & Solubility Information
StorageIn solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 125 mg/mL (283.11 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (4.53 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.2649 mL11.3245 mL22.6490 mL113.2452 mL
5 mM0.4530 mL2.2649 mL4.5298 mL22.6490 mL
10 mM0.2265 mL1.1325 mL2.2649 mL11.3245 mL
20 mM0.1132 mL0.5662 mL1.1325 mL5.6623 mL
50 mM0.0453 mL0.2265 mL0.4530 mL2.2649 mL
100 mM0.0226 mL0.1132 mL0.2265 mL1.1325 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy ML355 | purchase ML355 | ML355 cost | order ML355 | ML355 chemical structure | ML355 formula | ML355 molecular weight